CLINICAL_TRIALS
trial_result
· 2025-01-23
Clinical Trial Update: Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation [Phase 1]
Summary
Phase 1 trial evaluating tributyrin supplementation in Parkinson's disease was terminated. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nicolaas Bohnen, MD, PhD | Conditions: Parkinson Disease | Phase 1 | Status: TERMINATED | Results posted: 2025-01-23